Skip to main content
Top

2019 | OriginalPaper | Hoofdstuk

12. The normal and abnormal menstrual cycle

Auteurs : Joop S. E. Laven, Nils B. Lambalk

Gepubliceerd in: Textbook of Obstetrics and Gynaecology

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Summary

The regulation of the menstrual cycle in women is an intricate interplay between the hypothalamic, pituitary and gonadal hormones. Immediately following menarche most menstrual cycles are anovulatory and hence the interval between menstruations is slightly irregular. After 2–4 years most girls will have regular periods. However, a small number will continue to have irregular or even absent menses. Other women will develop irregular cycles later on in life as they gain weight. In others the disappearance of menses might be associated with other disturbing symptoms. Anovulatory cycles are classified as having central, peripheral or combined causes. Apart from subfertility, anovulation is also associated with other short-term as well as long-term health issues such as hirsutism, obesity, metabolic syndrome, cardiovascular disease, osteoporosis and type 2 diabetes mellitus. Therefore, women with irregular menstrual cycles deserve proper medical attention, appropriate care and sufficient follow-up during their whole lifespan in order to prevent and timely treat some of the disturbing symptoms and health sequelae later on in life.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Woordenlijst
Anovulatory
Not having regular ovulations
Oligomenorrhoea
Interval between menses exceeding 35
Polymenorrhoea
Interval being shorter than 21 days
Amenorrhoea
No menses at all or interval exceeding 199 days
Menarche
First menstrual period ever
Menopause
Last menstrual period
Hypogonadotropic hypogonadism
Absent ovarian activity due to lack of central stimulation
Normogonadotropic normo-oestrogenic anovulation
Combined central and peripheral cause of anovulation
PCOS
Polycystic ovary syndrome
Hypergonadotropic hypogonadism
Irresponsive ovary due to absence of follicles
POI
Primary ovarian insufficiency
Kallmann syndrome
Anosmic hypogonadotropic hypogonadism
Hirsutism:
Hair overgrowth
Androgenic alopecia
Male type of scalp hair loss in women
Osteopenia
Low bone mineral density, T score between −1.0 and −2.5.
Osteoporosis
Decreased (too low) bone mineral density T score lower than −2.6
Anosmia
Loss of the sense of smell
Laparoscopic ovarian diathermy (LOD) (drilling)
Destruction of ovarian tissue using electro-cauterization
Hormone replacement therapy (HRT)
Replacement of oestrogens and progestogens in order to replace the missing sex steroids
Literatuur
1.
go back to reference Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Hum Reprod. 2012;27:14–24. Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Hum Reprod. 2012;27:14–24.
2.
go back to reference Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nat Rev Dis Primers 2016;2:16057.CrossRef Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nat Rev Dis Primers 2016;2:16057.CrossRef
3.
go back to reference Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, Stener-Victorin E, Fauser BC, Norman RJ, Teede H. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 2016;22:687–708.CrossRef Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, Stener-Victorin E, Fauser BC, Norman RJ, Teede H. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 2016;22:687–708.CrossRef
4.
go back to reference Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36:487–525.CrossRef Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36:487–525.CrossRef
5.
go back to reference Luisi S, Orlandini C, Regini C, Pizzo A, Vellucci F, Petraglia F. Premature ovarian insufficiency: from pathogenesis to clinical management. J Endocrinol Invest. 2015;38:597–603.CrossRef Luisi S, Orlandini C, Regini C, Pizzo A, Vellucci F, Petraglia F. Premature ovarian insufficiency: from pathogenesis to clinical management. J Endocrinol Invest. 2015;38:597–603.CrossRef
6.
go back to reference Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A, Maciejewska-Jeske M. Functional hypothalamic amenorrhoea and its influence on women’s health. J Endocrinol Invest. 2014;37:1049–56.CrossRef Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A, Maciejewska-Jeske M. Functional hypothalamic amenorrhoea and its influence on women’s health. J Endocrinol Invest. 2014;37:1049–56.CrossRef
7.
go back to reference Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7.CrossRef Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7.CrossRef
8.
go back to reference Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008;23:462–77. Erratum in: Hum Reprod. 2008;23:1474. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008;23:462–77. Erratum in: Hum Reprod. 2008;23:1474.
9.
go back to reference Trofimova T, Lizneva D, Suturina L, Walker W, Chen YH, Azziz R, Layman LC. Genetic basis of eugonadal and hypogonadal female reproductive disorders. Best Pract Res Clin Obstet Gynaecol. 2017;44:3–14. CrossRef Trofimova T, Lizneva D, Suturina L, Walker W, Chen YH, Azziz R, Layman LC. Genetic basis of eugonadal and hypogonadal female reproductive disorders. Best Pract Res Clin Obstet Gynaecol. 2017;44:3–14. CrossRef
10.
go back to reference Vos M de, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010;376:911–21. Vos M de, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010;376:911–21.
Metagegevens
Titel
The normal and abnormal menstrual cycle
Auteurs
Joop S. E. Laven
Nils B. Lambalk
Copyright
2019
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2131-5_12